Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818493 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty
A Phase 2 study, sponsored by QRxPharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT00818493: Completed Phase 2 study, sponsored by QRxPharma.
NCT00818493 is a Phase 2 study that has completed, run by QRxPharma. The registered enrollment target is 44 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00818493, a Phase 2 study, has completed, sponsored by QRxPharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
This is a Phase 2 3-arm, open label pilot study of the safety and efficacy of Q8003 in patients who have undergone primary unilateral total knee arthroplasty or total hip arthroplasty.
Interventions
- DRUG Q8003 (morphine sulfate and oxycodone hydrochloride)
- DRUG Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)
- DRUG Percocet (oxycodone and acetaminophen)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
What the finished NCT00818493 record still lists
NCT00818493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 3 interventions - of which Q8003 (morphine sulfate and oxycodone hydrochloride) is the first listed.
NCT00818493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00818493 about?
NCT00818493 is a clinical study titled "Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty". This is a Phase 2 3-arm, open label pilot study of the safety and efficacy of Q8003 in patients who have undergone primary unilateral total knee arthroplasty or total hip arthroplasty.
What is the current status of trial NCT00818493?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2009-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00818493?
The interventions under investigation include: Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG), Low dose Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG), Percocet (oxycodone and acetaminophen) (DRUG).
Who is sponsoring clinical trial NCT00818493?
This trial is sponsored by QRxPharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00818493's enrollment target sits among peer trials
44 1322nd of 2000 higher than 669 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia